Search hospitals > Tennessee > Knoxville
New Orleans Center for Clinical Research
Claim this profileKnoxville, Tennessee 37920
Global Leader in Multiple Sclerosis
Global Leader in Type 2 Diabetes
Conducts research for Diabetes
Conducts research for Kidney Failure
Conducts research for Cardiovascular Disease
112 reported clinical trials
3 medical researchers
Summary
New Orleans Center for Clinical Research is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Multiple Sclerosis, Type 2 Diabetes, Diabetes, Kidney Failure, Cardiovascular Disease and other specialties. New Orleans Center for Clinical Research is involved with conducting 112 clinical trials across 133 conditions. There are 3 research doctors associated with this hospital, such as Evelyne M Davidson, Natalie L Clarke, and Davidson.Top PIs
Evelyne M DavidsonNew Phase Research and Development4 years of reported clinical research
Studies Chronic Obstructive Pulmonary Disease
Studies Obesity
8 reported clinical trials
13 drugs studied
Natalie L ClarkeNew Phase Research & Development3 years of reported clinical research
Studies Neuralgia
Studies Neuropathic Pain
2 reported clinical trials
4 drugs studied
DavidsonNew Phase Research & Development2 years of reported clinical research
Studies Cardiovascular Disease
Studies Atherosclerosis
1 reported clinical trial
2 drugs studied
Clinical Trials running at New Orleans Center for Clinical Research
Multiple Sclerosis
Type 2 Diabetes
Cardiovascular Disease
Interstitial Cystitis
Neuralgia
Syndrome
Diabetes
Neuropathic Pain
Acute Coronary Syndrome
Obesity
Ofatumumab
for Multiple Sclerosis
This trial will test if patients with a specific type of multiple sclerosis benefit from switching to a new medication. The medication aims to reduce harmful cells in the nervous system, potentially preventing future issues. It has been approved in several countries for treating this condition.
Recruiting3 awards Phase 410 criteria
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at New Orleans Center for Clinical Research?
New Orleans Center for Clinical Research is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Multiple Sclerosis, Type 2 Diabetes, Diabetes, Kidney Failure, Cardiovascular Disease and other specialties. New Orleans Center for Clinical Research is involved with conducting 112 clinical trials across 133 conditions. There are 3 research doctors associated with this hospital, such as Evelyne M Davidson, Natalie L Clarke, and Davidson.